GHK-Cu (Copper Peptide): What Lakeland Readers Should Know

GHK-Cu, often called copper peptide, shows up in serums, creams and hair products, and some clinics also offer it as an injection. This page explains what it is, what the human research actually shows and how topical and injected use differ. It is general information, not advice for your situation.

What it is and how it works

GHK is a very small peptide made of three amino acids: glycine, histidine and lysine. The body makes it naturally, and it is found in blood plasma, saliva and urine. It is released from collagen and another tissue protein when tissue is injured. GHK binds tightly to copper, and the copper-bound form is called GHK-Cu. On ingredient labels it often appears as “copper tripeptide-1.” It was first described in 1973.¹

Researchers have proposed that GHK-Cu acts as a repair signal after injury. One idea is that it delivers copper to an enzyme that helps link collagen fibers together. Other proposed effects on collagen, inflammation and antioxidant activity come from cell and animal work.²

The research group that first studied GHK reports that blood levels fall from about 200 ng/mL at age 20 to about 80 ng/mL by age 60. That figure comes from a group with commercial ties to the peptide, and it is widely repeated in marketing.² Lower levels with age do not by themselves show that adding more helps.

GHK-Cu is used in two very different ways: on the skin in cosmetic products, and as an injection offered by some clinics. On its own, GHK-Cu barely passes through intact skin in lab tests. Pretreating skin with microneedling increased delivery in lab models, but this has not been confirmed in large human studies.¹

What the research shows (and where evidence is weak)

A 2026 systematic review (a study that gathers all the published research on a question) included 64 records on GHK-Cu. It described the human evidence as “a handful of small trials and series,” mostly on cosmetic creams. Most had fewer than 100 people and ran 8 to 16 weeks. Many did not clearly report how people were assigned to groups or whether assessors were blinded.¹

Cosmetic creams.

• The most-quoted studies, a face cream tested in 71 women and an eye cream in 41 women, were 2002 conference abstracts. Neither was ever published as a full peer-reviewed paper.¹
• In a randomized trial of 13 patients after laser skin resurfacing, computer analysis and blinded evaluators found no difference between groups in redness, wrinkles or overall skin quality. Patients using GHK-Cu products did rate their skin quality as better.³ “Randomized” means people were assigned to groups by chance.
• In a 2025 acne-scar study, as summarized in the 2026 review, GHK-Cu serum with microneedling showed an early edge over microneedling alone. By week 16 there was no difference, and the authors flagged a risk of skin darkening.¹

Wound gel (1990s). A multicenter, randomized, placebo-controlled trial of a GHK-Cu gel for diabetic foot ulcers reported more ulcer closure than a placebo gel.⁴ Trade press in 1994 reported a later trial was negative; full results were not published.⁵ The gel never became an approved drug.

Injections. No human trials of injected GHK-Cu were found. A 2026 review for orthopaedic and sports doctors found “no clinical data” supporting its use for muscle, tendon or joint problems.⁶

Who did the research. About 35% of recent GHK-Cu research includes authors from one company-linked group, which limits how independent the evidence is.¹ Claims that GHK-Cu “resets” genes come from that group’s computer analyses of gene activity in cells, not from health outcomes in people.²

FDA and regulatory status

Not an approved drug. GHK-Cu is sold as a cosmetic ingredient. No FDA drug approval for it was found in the research behind this page.

Injectable GHK-Cu. FDA had placed injectable GHK-Cu on its “Category 2” list of bulk ingredients that may pose significant safety risks in compounding. By April 22, 2026, the nominations were withdrawn; FDA still lists its safety concerns. It says injections may cause immune reactions because of clumping and impurities, and that “there are limited data in humans.”⁷

Non-injectable GHK-Cu. FDA’s compounding nominations list, updated May 14, 2026, says non-injectable GHK-Cu is being returned to Category 1, the group FDA is still evaluating. FDA intends to consult its compounding advisory committee about it before the end of February 2027.⁸ As of November 13, 2026, we did not find a meeting date or outcome for that review. Check FDA’s compounding nominations list for updates.

2026 HHS draft policy. According to law-firm summaries, GHK-Cu is not among the six peptides in HHS’s October 2026 draft compounding enforcement policy.⁹¹⁰

Sport. GHK-Cu is not named on WADA’s 2026 Prohibited List.¹¹ Injected use is likely covered by WADA’s ban on unapproved substances; athletes should check with their anti-doping organization.

Injectable GHK-Cu is also sold online as a “research chemical.” Read more in our guide to research chemical peptide risks.

Common side effects and safety

• Limited safety data. The original research group calls GHK “safe” and says it has been used in cosmetics for decades without adverse effects.² That is not backed by controlled human safety studies, and FDA says human data are limited.⁷
• Injections. FDA’s concern is immune reactions linked to clumping and impurities in manufactured product.⁷ A 2026 sports-medicine review noted that rigorous human safety data for unapproved peptides are scarce and that serious harm is possible.¹²
• Skin darkening. In the acne-scar study using microneedling, researchers flagged a risk of hyperpigmentation (darker patches of skin).¹
• Copper. If you have a condition that affects how your body handles copper, or a copper allergy, ask a provider before using any copper peptide product.

If you have a reaction to any product, stop using it and tell a licensed provider.

Typical cost range

There is no reliable price data. The original research group describes GHK as an inexpensive cosmetic ingredient.² There is no official list price for a GHK-Cu drug. Prices vary by product, brand and seller. Ask any provider for a written price breakdown before you start.

Our Polk County cost guide covers what to ask about pricing.

Questions to ask a provider

• For my goal, is a topical product enough? Why would I need an injection?
• Since injected GHK-Cu has never been tested in human trials, what evidence supports it for me?
• Where does an injectable product come from, and which state-licensed pharmacy makes it?
• Are there better-studied options for my skin or hair goal?
• What side effects should I watch for, and how do I reach you?
• What is the total cost, and what does it include?

See also our guides on compounded vs FDA-approved peptides and how to vet a peptide clinic.